Nicholas Lydon

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Melissa Masse
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicholas Lydon:

Company Role Class Num Shares Value Price $ Report Date Ownership
Blueprint Medicines Corp Director Common Stock 58,026 $6,100,273 $105.13 12 Jun 2024 Direct
Blueprint Medicines Corp Director Stock Option (Right to Buy) 4,570 $68,596 $15.01 12 Jun 2024 Direct

Insider Reports Filed by Nicholas Lydon

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BPMC Blueprint Medicines Corp 12 Jun 2024 2 $0 4 Director 14 Jun 2024, 17:34
BPMC Blueprint Medicines Corp 21 Jun 2023 2 $0 4 Director 23 Jun 2023, 19:02
BPMC Blueprint Medicines Corp 21 Jun 2022 2 $0 4 Director 30 Jun 2022, 21:56
BPMC Blueprint Medicines Corp 23 May 2022 2 +$213,053 4 Director 25 May 2022, 16:05
BPMC Blueprint Medicines Corp 02 Jun 2021 2 $0 4 Director 04 Jun 2021, 16:14